Literature DB >> 27867589

Bruton's agammaglobulinemia in an adult male due to a novel mutation: a case report.

Yuanda Xu1, Qi Qing1, Xuesong Liu1, Sibei Chen1, Ziyi Chen2, Xuefeng Niu1, Yaxia Tan1, Weiqun He1, Xiaoqing Liu1, Yimin Li1, Rongchang Chen1, Ling Chen3.   

Abstract

X-linked agammaglobulinemia (XLA) is caused by mutation in the gene coding for Bruton's tyrosine kinase (BTK), which impairs peripheral B cell maturation and hypogammaglobulinemia. In this report, we present a case of XLA in a 22-year-old adult male. Genetic testing revealed a novel mutation located at the conserved region (c.383T>C). The patient had a history of recurrent respiratory tract infection which eventually progressed to chronic type II respiratory failure. Several pathogenic bacteria were isolated on culture of respiratory secretions obtained on bronchoscopy. The patient improved on treatment with antibiotics.

Entities:  

Keywords:  X-linked agammaglobulinemia (XLA); novel mutation

Year:  2016        PMID: 27867589      PMCID: PMC5107543          DOI: 10.21037/jtd.2016.10.12

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  23 in total

Review 1.  X-linked agammaglobulinemia.

Authors:  M E Conley; J Rohrer; Y Minegishi
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

2.  The health status and quality of life of adults with X-linked agammaglobulinemia.

Authors:  Vanessa Howard; Jeffrey M Greene; Savita Pahwa; Jerry A Winkelstein; John M Boyle; Mehmet Kocak; Mary Ellen Conley
Journal:  Clin Immunol       Date:  2005-12-22       Impact factor: 3.969

3.  Agammaglobulinemia.

Authors:  O C BRUTON
Journal:  Pediatrics       Date:  1952-06       Impact factor: 7.124

4.  Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies).

Authors:  M E Conley; L D Notarangelo; A Etzioni
Journal:  Clin Immunol       Date:  1999-12       Impact factor: 3.969

5.  Clinical characteristics and genotype-phenotype correlation in 62 patients with X-linked agammaglobulinemia.

Authors:  Pamela P W Lee; Tong-Xin Chen; Li-Ping Jiang; Koon-Wing Chan; Wanling Yang; Bee-Wah Lee; Wen-Chin Chiang; Xiang-Yuan Chen; Susanna F S Fok; Tsz-Leung Lee; Marco H K Ho; Xi-Qiang Yang; Yu-Lung Lau
Journal:  J Clin Immunol       Date:  2009-11-11       Impact factor: 8.317

6.  Antigen presentation under the influence of 'immune evasion' proteins and its modulation by interferon-gamma: implications for immunotherapy of cytomegalovirus infection with antiviral CD8 T cells.

Authors:  Annette Fink; Niels A W Lemmermann; Dorothea Gillert-Marien; Doris Thomas; Kirsten Freitag; Verena Böhm; Vanessa Wilhelmi; Kurt Reifenberg; Matthias J Reddehase; Rafaela Holtappels
Journal:  Med Microbiol Immunol       Date:  2012-09-09       Impact factor: 3.402

7.  The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases.

Authors:  D Vetrie; I Vorechovský; P Sideras; J Holland; A Davies; F Flinter; L Hammarström; C Kinnon; R Levinsky; M Bobrow
Journal:  Nature       Date:  1993-01-21       Impact factor: 49.962

8.  Early therapy with IgM-enriched polyclonal immunoglobulin in patients with septic shock.

Authors:  Ilaria Cavazzuti; Giulia Serafini; Stefano Busani; Laura Rinaldi; Emanuela Biagioni; Marta Buoncristiano; Massimo Girardis
Journal:  Intensive Care Med       Date:  2014-09-13       Impact factor: 17.440

Review 9.  X-linked primary immunodeficiencies as a bridge to better understanding X-chromosome related autoimmunity.

Authors:  Itai M Pessach; Luigi D Notarangelo
Journal:  J Autoimmun       Date:  2009-04-09       Impact factor: 7.094

10.  Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18.

Authors:  Virginie Prod'homme; Peter Tomasec; Charles Cunningham; Marius K Lemberg; Richard J Stanton; Brian P McSharry; Eddie C Y Wang; Simone Cuff; Bruno Martoglio; Andrew J Davison; Véronique M Braud; Gavin W G Wilkinson
Journal:  J Immunol       Date:  2012-02-15       Impact factor: 5.422

View more
  2 in total

1.  Molecular alterations in the integrated diagnosis of pediatric glial and glioneuronal tumors: A single center experience.

Authors:  Sandra Lorena Colli; Nazarena Cardoso; Carla Antonella Massone; María Cores; Mercedes García Lombardi; Elena Noemí De Matteo; Mario Alejandro Lorenzetti; María Victoria Preciado
Journal:  PLoS One       Date:  2022-04-01       Impact factor: 3.240

2.  Mucosal IgA Prevents Commensal Candida albicans Dysbiosis in the Oral Cavity.

Authors:  Nicolas Millet; Norma V Solis; Marc Swidergall
Journal:  Front Immunol       Date:  2020-10-22       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.